Please login to the form below

Not currently logged in
Email:
Password:

Rapivab

This page shows the latest Rapivab news and features for those working in and with pharma, biotech and healthcare.

BioCryst gets FDA nod for first intravenous flu drug

BioCryst gets FDA nod for first intravenous flu drug

BioCryst gets FDA nod for first intravenous flu drug. Expects to launch Rapivab in time for this year's flu season. ... The FDA gave the go-ahead yesterday for Rapivab (peramivir) to treat flu in adults who have been symptomatic for no more than two days,

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Pharma deals in June 2015 Pharma deals in June 2015

    85. BioCryst Pharmaceuticals/ CSL. RAPIVAB (peramivir injection) for the treatment of influenza (marketed).

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics